Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |